SquareMind, a Paris-based medical robotics company, secured $18 million in funding including a pre-Series A round backed by Fred Moll's Sonder Capital. The company's flagship Swan robot leverages artificial intelligence to perform full-body dermoscopic skin imaging, representing an advancement in dermatological diagnostic technology.
SquareMind secured $18 million in funding, led by Sonder Capital, to advance its AI and robotics solutions for dermatology skin examinations. The investment aims to make high-quality, consistent skin exams more accessible at scale. Sonder Capital's co-founder Fred Moll is a medical robotics pioneer known for founding Intuitive Surgical.